KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

BioNTech SE (BNTX) Income from Continuing Operations (2018 - 2025)

BioNTech SE's Income from Continuing Operations history spans 8 years, with the latest figure at 355033271.98 for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations fell 228.03% to 355033271.98 in Q4 2025 year-over-year; TTM through Dec 2025 was 1300023420.39, a 54.73% decrease, with the full-year FY2025 number at 1283578492.83, down 74.06% from a year prior.
  • Income from Continuing Operations hit 355033271.98 in Q4 2025 for BioNTech SE, down from 33551881.12 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for BNTX hit a ceiling of 4151302752.66 in Q1 2022 and a floor of 869909784.13 in Q2 2024.
  • Historically, Income from Continuing Operations has averaged 1101645792.31 across 5 years, with a median of 406468101.3 in 2023.
  • Biggest five-year swings in Income from Continuing Operations: soared 827987404.69% in 2021 and later tumbled 319.57% in 2024.
  • Tracing BNTX's Income from Continuing Operations over 5 years: stood at 3622040825.48 in 2021, then increased by 14.54% to 4148835910.98 in 2022, then plummeted by 88.13% to 492672884.32 in 2023, then crashed by 43.72% to 277300506.34 in 2024, then crashed by 228.03% to 355033271.98 in 2025.
  • Business Quant data shows Income from Continuing Operations for BNTX at 355033271.98 in Q4 2025, 33551881.12 in Q3 2025, and 474064717.33 in Q2 2025.